NCT01739673已完成不适用
Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Cxlusa
- 入组人数
- 13
- 试验地点
- 7
- 主要终点
- Resolution of Signs and Symptoms of Infectious Keratitis
研究概览
简要总结
This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects must be 18 years of age or older.
- •Ability to provide written informed consent.
- •Likely to complete all study visits.
- •Subjects must have one eye that with a diagnosis of infectious keratitis.
排除标准
- •A corneal perforation.
- •Descemetocele.
- •Pregnancy or breastfeeding.
- •Active Herpes corneal disease.
- •Patient is unwilling or unable to comply with a medication regimen and follow up appointments.
结局指标
主要结局
Resolution of Signs and Symptoms of Infectious Keratitis
时间窗: Subjects will be followed until resolution of signs and symptoms, an expected average of 8 weeks
次要结局
未报告次要终点
研究者
研究点 (7)
Loading locations...
相似试验
已完成
2 期
Corneal Crosslinking in Patients With Keratoconus and Post-Refractive EctasiaPost-Refractive EctasiaKeratoconusNCT01143389Price Vision Group510
已完成
不适用
The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous KeratopathyBullous KeratopathyNCT01106274Mashhad University of Medical Sciences20
已完成
1 期
Use of Cross-linked Donor Corneas as Carriers for the Boston KeratoprosthesisChemical InjuriesUnspecified Complication of Corneal TransplantAutoimmune DiseasesOcular Cicatricial PemphigoidStevens Johnson SyndromeLupus Erythematosus, SystemicOther Autoimmune DiseasesRheumatoid ArthritisNCT01582880Joseph B. Ciolino, MD1
Unknown
2 期
UVA-Riboflavin Crosslinking Treatment of Corneal EctasiaEctasiaCorneal EctasiaKeratoconusNCT01325298Mercy Center for Corrective Eye Surgery250
已完成
不适用
Evaluation of efficacy and safety of riboflavin/UVA treatment for keratoconus/keratectasiaJPRN-UMIN000002947Department of Ophthalmology, Keio University School of Medicine30
